MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2023: Top 20 Genomics Companies in the World
Krystal Biotech, Inc, (NASDAQ: KRYS)
Organization & Developments: Krystal Biotech
Parents
Krystal Biotech, Inc, (NASDAQ: KRYS)
Children
2018: Krystal Biotech: Data Due Year-End_seekingalpha.com
2018: Krystal Biotech: Update And 2019 Outlook_seekingalpha.com
2022: Krystal Biotech: A Buy For Growth Potential_ seekingalpha.com
2023: Krystal Biotech: 2 Potential Regulatory Approvals To Carry It Forward_seekingalpha.com
2023: Krystal Biotech's Vyjuvek Impresses Early On, Bolsters Prospects_ seekingalpha.com
2024: Krystal Biotech Plans to Advance Eyedrop Gene Therapy That Cured Blindness in Teen Patient
2024: Krystal Biotech touts topical gene therapy uptake, plots overseas launches
2024: Krystal Biotech touts topical gene therapy uptake, plots overseas launches
2024: Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy_seekingalpha.com
2024: Krystal Biotech: Q4 Catalysts Expected With VYJUVEK Revenue Growth Pressing On
2024: Krystal Biotech: Ready For Launch
2024: Krystal Biotech's Future Brightens With Vyjuvek's Robust Launch
2025: Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus
2025:Is Abeona Therapeutics' Zevaskyn Worth $3.1m Per Treatment, Or Will Krystal Biotech Remain The Market Leader?
Jumps
*Key People: Krystal Biotech
Finance & Acquisitions: Krystal Biotech